đź“Ł ADDS 2027 Save the Date!
We hope you'll join us for our 5th meeting, ADDS 2027, taking place Feb 8-10, 2027 in Atlanta, GA.

Office Closure: Due to Hurricane Isaias, Ametris' offices will be closed Friday, October 9th.
We will reopen at regular business hours on Monday, October 12th.
Subscribe to Receive Updates

Educational

Resources

Explore Ametris' educational resources to gain a deeper understanding of Digital Health Technologies in clinical trials.

Resources-header-gfx
Popular Searches:
Optimizing Wearable Adherence in a Phase 3 Oncology Trial Through Real-Time Data Workflows Featured Resource

Optimizing Wearable Adherence in a Phase 3 Oncology Trial Through Real-Time Data Workflows

Ametris partnered with Johnson & Johnson Innovative Medicine to improve wearable adherence in the global Phase 3 LIBERTAS trial for a metastatic castration-sensitive prostate cancer (mCSPC) therapy. In this study, actigraphy devices were used for more than 12 months to continuously measure sleep quality and physical activity as objective proxies for hot flash burden.

View Resource

Schedule a Meeting with Our Science Team

Ready to accelerate your DHT strategy? Our experts can help. Schedule a meeting with a member of our Science Team to receive personalized guidance on maximizing the benefits of DHTs throughout the clinical development lifecycle.

Get in Touch